de Groot K, Harper L, Jayne DR, Flores Suarez LF, Gregorini G, Gross WL, et al. Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial. Ann Intern Med 2009;150(10):670-80. https://www.ncbi.nlm.nih.gov/pubmed/19451574
Unizony S, Stone J. Antineutrophil cytoplasmic antibody–associated vasculitis. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH. Rheumatology. 6th ed. Philadelphia, PA: Mosby/Elsevier; 2015. p. 1310-21. https://www.sciencedirect.com/book/9780323091381/rheumatology
Walsh M, Merkel PA, Peh CA, Szpirt WM, Puechal X, Fujimoto S, et al. Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis. N Engl J Med 2020;382(7):622-31. https://www.ncbi.nlm.nih.gov/pubmed/32053298
Yates M, Watts RA, Bajema IM, Cid MC, Crestani B, Hauser T, et al. EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum Dis 2016;75(9):1583-94. https://www.ncbi.nlm.nih.gov/pubmed/27338776
